Document is current
Any future updates will be listed below
-
Authors
Yadavalli, Chandra Sekhar
Upparahalli Venkateshaiah, Sathisha
Kumar, Sandeep
Kandikattu, Hemanth Kumar
Oruganti, Lokanatha
Kathera, Chandra Sekhar
Mishra, Anil https://orcid.org/0000-0003-4266-4684
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 AI080581)
- License Information
-
More Information
Article History
Received: 5 January 2023
Accepted: 10 July 2023
First Online: 31 July 2023
Competing interests
: The authors declare that they have no known competing personal relationships that could have appeared to influence the work reported in this paper. However, A.M. filed a patent to protect using humanized antagonist or anti-antibody of NLRP3-Caspase1-IL-18 for targeting human eosinophils associated disease pathogenesis.
